Mesenchymal stem cells (MSCs) are non-hematopoietic progenitor cells, which can be
isolated from different types of tissues including bone marrow, adipose tissue, tooth pulp …

Tumors often overcome the cytotoxic effects of chemotherapy through either acquired or
environment-mediated drug resistance. In addition, signals from the microenvironment …

Mesenchymal stem cells (MSCs), as an undifferentiated group of adult multipotent cells,
have remarkable antitumor features that bring them up as a novel choice to treat cancers …

Mesenchymal stem cells (MSCs) are multipotent stem cells with the capacity to differentiate
into several cell types under appropriate conditions. They also possess remarkable …

Background The therapeutic capacity of mesenchymal stem cells (also known as
mesenchymal stromal cells/MSCs) depends on their ability to respond to the need of the …

Targeting actionable mutations in oncogene‐driven cancers and the evolution of immuno‐
oncology are the two prominent revolutions that have influenced cancer treatment …

A newly synthesized nanoplatform of hyaluronic acid and chitosan nanoparticles (HA/CNPs)
was applied to improve the therapeutic efficacy and protection of bone marrow …

Chemotherapeutic agents are part of the standard treatment algorithms for many
malignancies; however, their application and dosage are limited by their toxic effects to …

Mesenchymal stem cells (MSCs) are an integral part of the bone marrow niche and aid in
the protection, regeneration and proliferation of hematopoietic stem cells after exposure to …

Mesenchymal stem cells (MSCs) have been shown to attenuate pulmonary damage induced
by bleomycin-based anticancer treatments, but the influence of bleomycin on the stem cells …